• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Protein Capture Agents with 40 °C Shelf Life for Developing World Point-of-Care HIV-1 Diagnostics

James Heath of the California Institute of Technology in the U.S. will work to develop protein catalyzed capture agents, which are synthetically-created peptides that may act as drop-in replacements for antibodies in diagnostic assays. These agents, designed to be stable up to 40°C for extended periods, aim to be as sensitive as antibodies, but due to their chemical structure, more easily transported, stored, and used in various diagnostic platforms in developing world settings.

More information about Point-of-Care Diagnostics

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.